These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21280519)

  • 1. Comparison of changes of body water measured by using bioelectrical impedance analysis between lercanidipine and amlodipine therapy in hypertensive outpatients.
    Sansanayudh N; Wongwiwatthananukit S; Veerayuthvilai S
    J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S84-92. PubMed ID: 21280519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study.
    Barrios V; Escobar C; de la Figuera M; Llisterri JL; Honorato J; Segura J; Calderón A
    Cardiovasc Ther; 2008; 26(1):2-9. PubMed ID: 18466416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study.
    Martinez-Martin FJ; Saiz-Satjes M
    Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1347-55. PubMed ID: 19018688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azelnidipine and amlodipine: a comparison of their effects and safety in a randomized double-blinded clinical trial in Chinese essential hypertensive patients.
    Zhao X; Wu F; Jia S; Qu P; Li H; Zhao X; Cao B; Lin Y; Wang M
    Clin Exp Hypertens; 2010; 32(6):372-6. PubMed ID: 21029001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manidipine in hypertensive patients with metabolic syndrome: the MARIMBA study.
    Martínez Martín FJ
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):863-9. PubMed ID: 19589122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of psychosomatic symptomatology in hypertensive patients treated with lercanidipine (LERCAPSICO study)].
    Abellán Alemán J; Martínez García JF; Merino Sánchez J; Gil Guillén V; Latorre Hernández J; Fernández Montero F; Navarro Lima A;
    An Med Interna; 2003 Jun; 20(6):287-91. PubMed ID: 12848598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioelectrical impedance analysis to assess changes in body water compartments after digestive surgery.
    Hanaki N; Ishikawa M; Nishioka M; Kashiwagi Y; Miki H; Miyake H; Tashiro S
    Hepatogastroenterology; 2006; 53(71):723-9. PubMed ID: 17086877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
    Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
    Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of valsartan or olmesartan addition to amlodipine on ankle edema in hypertensive patients.
    Fogari R; Malamani G; Corradi L; Mugellini A; Preti P; Zoppi A; Derosa G
    Adv Ther; 2010 Jan; 27(1):48-55. PubMed ID: 20174905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lercanidipine, a third generation calcium antagonist. Which advantages?].
    Meier P; Burnier M
    Rev Med Suisse; 2006 Sep; 2(78):2047-50, 2052-3. PubMed ID: 17019840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of intracellular water by whole body bioelectrical impedance and total body potassium in HIV-positive patients.
    Schwenk A; Eschner W; Kremer G; Ward LC
    Clin Nutr; 2000 Apr; 19(2):109-13. PubMed ID: 10867728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine.
    Corea L; Cardoni O; Fogari R; Innocenti P; Porcellati C; Provvidenza M; Meilenbrock S; Sullivan J; Bodin F
    Clin Pharmacol Ther; 1996 Sep; 60(3):341-6. PubMed ID: 8841157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amlodipine improves endothelial function and metabolic parameters in patients with hypertension.
    Koh KK; Han SH; Ahn JY; Chung WJ; Lee Y; Shin EK
    Int J Cardiol; 2009 Mar; 133(1):23-31. PubMed ID: 18199500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
    Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY;
    Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Some aspects of the clinical use of lercamen (lercadipine)].
    Kavtaradze GV; Kostava MT; Gvetadze LG
    Georgian Med News; 2009; (172-173):50-3. PubMed ID: 19644190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Maruyama N; Matsumoto K
    Hypertens Res; 2009 Apr; 32(4):270-5. PubMed ID: 19262495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.